BIONET Therapeutics Corp.
Update：2023/07/25
Industries
Main Industry
Biotechnology
Main Product/Service
At BIONET Therapeutics Corp., our focus is on regenerative medicinal products, Advanced tech-enabled research and development, exosomes, and gene/cell therapy.
Founded Year
2022
Unified Business No.
90272474
Status
Active
Number of Employees
0
Total Paid-in
Capital
700,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2024)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Exclusive content for members
Members-only content. Please log in to access.
Introduction
BIONET Therapeutics Corp. is a patient-focused, R&D-driven global biopharmaceutical company, established in 2022. Our mission is to rapidly develop, manufacture, and provide regenerative medicine preparations and advanced cellular therapies to meet the evolving health needs of people at different stages of life. We are committed to staying at the forefront of this rapidly evolving field by prioritizing innovation, research, and development. With our patient-centered approach, we are dedicated to improving the lives of our patients and providing them with the highest level of care possible.
